Floatz logo

Cerebrolysin

Intracerebral Hemorrhage

Cardinal Stefan Wyszynski UniversitymixturePhase 4 / ApprovedActive
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
81/ 100

Competitive context

39 Active assets in the Intracerebral Hemorrhage cohort.

Asset / SponsorPhaseRating
Edoxaban
Population Health Research Institute
Phase 4BBB
Tranexamic Acid
Christian Medical College and Hospital, Ludhiana, India
Phase 4BB
Acetylsalicylic Acid
University Hospital, Lille
Phase 4BB
Rivaroxaban
Imperial College London
Phase 3BB
Valproic Acid
University of North Carolina, Chapel Hill
Phase 4BB

View all 50 →

Same molecule, other indications

Cerebrolysin is also rated in:

CerebrolysinDormant
BB
Indicative ·
67 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
66 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →